We are live on ! Find out more
DSCI

Derma Sciences, Inc. Common Stock (DE)
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

Back to rankings

Fund managers haven’t disclosed any holdings of DSCI yet.

DSCI Hedge Fund Activity: Q2 2017 in Review

0 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q2 2017, worth a combined $0 — down 100% from $1.61M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DSCI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was FNY Partners Fund, exiting entirely with an estimated $1.61M sold.

  • 0 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q2 2017, down from 1 in Q1 2017.
  • Funds reported $0 of Derma Sciences, Inc. Common Stock (DE) stock for Q2 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q2 2017 and 1 closed out, a net change of -1 holder.
  • The largest Derma Sciences, Inc. Common Stock (DE) seller in Q2 2017 was FNY Partners Fund, an estimated $1.61M sold.

Based on aggregated 13F filings for Q2 2017.